Literature DB >> 29957382

Up-regulation of μ-, δ- and κ-opioid receptors in concanavalin A-stimulated rat spleen lymphocytes.

Kristina Cechova1, Martina Hlouskova2, Eliska Javorkova3, Lenka Roubalova2, Hana Ujcikova2, Vladimir Holan3, Petr Svoboda4.   

Abstract

Regulation of μ-, δ- and κ-opioid receptor protein level in spleen lymphocytes when stimulated by mitogen is not known. To answer the question whether these cells do express opioid receptor (OR) proteins, primary, fresh rat spleen lymphocytes were prepared and stimulated for 48 h with mitogenic dose of Con A. The unstimulated lymphocytes did not express μ- and δ-OR proteins in detectable amounts, however, stimulation with Con A resulted in appearance of clearly detectable immunoblot signals of both μ-OR and δ-OR. κ-OR were detected already in primary cells and increased 2.4-fold in Con A-stimulated cells. These results were supported by data obtained by flow cytometry analysis indicating a dramatic increase in number of μ-, δ- and κ-OR expressing cells after mitogen stimulation. The newly synthesized μ-, δ- and κ-OR in Con A-stimulated spleen lymphocytes were present in the cells interior and not functionally mature, at least in terms of their ability to enhance activity of trimeric G proteins determined by three different protocols of agonist-stimulated, high-affinity [35S]GTPγS binding assay. The up-regulation of μ-, δ- and κ-OR was associated with specific decrease of their cognate trimeric G proteins, Gi1α/Gi2α; the other Gα and Gβ subunits were unchanged. The level of β-arrestin-1/2 was also decreased in Con A-stimulated splenocytes. We conclude that up-regulation of OR expression level in spleen lymphocytes by Con A proceeds in conjunction with down-regulation of their intracellular signaling partners, Gi1α/Gi2α proteins and β-arrestin-1/2. These regulatory proteins are expressed in high amounts already in unstimulated cells and decreased by mitogen stimulation.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Concanavalin A; G proteins; Opioids receptors; Rat spleen lymphocytes; Up-regulation; β-arrestin-1/2

Mesh:

Substances:

Year:  2018        PMID: 29957382     DOI: 10.1016/j.jneuroim.2018.05.008

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  6 in total

Review 1.  cAMP guided his way: a life for G protein-mediated signal transduction and molecular pharmacology-tribute to Karl H. Jakobs.

Authors:  Klaus Aktories; Peter Gierschik; Dagmar Meyer Zu Heringdorf; Martina Schmidt; Günter Schultz; Thomas Wieland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-05-17       Impact factor: 3.000

2.  The Impact of Morphine on the Characteristics and Function Properties of Human Mesenchymal Stem Cells.

Authors:  Vladimir Holan; Kristina Cechova; Alena Zajicova; Jan Kossl; Barbora Hermankova; Pavla Bohacova; Michaela Hajkova; Magdalena Krulova; Petr Svoboda; Eliska Javorkova
Journal:  Stem Cell Rev Rep       Date:  2018-12       Impact factor: 5.739

Review 3.  Role of neurotransmitters in immune-mediated inflammatory disorders: a crosstalk between the nervous and immune systems.

Authors:  Mojgan Oshaghi; Masoumeh Kourosh-Arami; Maryam Roozbehkia
Journal:  Neurol Sci       Date:  2022-09-28       Impact factor: 3.830

Review 4.  A "Drug-Dependent" Immune System Can Compromise Protection against Infection: The Relationships between Psychostimulants and HIV.

Authors:  María Amparo Assis; Pedro Gabriel Carranza; Emilio Ambrosio
Journal:  Viruses       Date:  2021-04-21       Impact factor: 5.048

Review 5.  Expression of Opioid Receptors in Cells of the Immune System.

Authors:  Jana Brejchova; Vladimir Holan; Petr Svoboda
Journal:  Int J Mol Sci       Date:  2020-12-30       Impact factor: 5.923

6.  The Dose-Dependent Effects of Multifunctional Enkephalin Analogs on the Protein Composition of Rat Spleen Lymphocytes, Cortex, and Hippocampus; Comparison with Changes Induced by Morphine.

Authors:  Hana Ujcikova; Lenka Roubalova; Yeon Sun Lee; Jirina Slaninova; Jana Brejchova; Petr Svoboda
Journal:  Biomedicines       Date:  2022-08-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.